Depending on the counter-receptor and its glycosylation, galectin-1 can differentially affect a variety of cellular functions, including cell proliferation [24,28,29], adhesion and migration [24,30,31], apoptosis in activated T lymphocytes [21,32], and induction of anoikis in pancreatic carcinoma cells [33]. The gene discussed is LGALS1; the disease is exocrine pancreatic carcinoma.